Clinical trial
Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic Carcinoma
NCT04567875 is registered in ClinicalTrials.gov with Ospedale Andrea Tortora di Pagani as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic Carcinoma
- Lead sponsor
- Ospedale Andrea Tortora di Pagani
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 16, 2020
- Completion date
- September 30, 2022
- Enrollment
- 54 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
castration-resistant prostate cancer